Article
Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.
Pediatric research - 1 May 2021
Burstein Danielle S, Gaynor J William, Griffis Heather, Ritter Alyssa, Connor Matthew J O', Rossano Joseph W, Lin Kimberly Y, Ahrens-Nicklas Rebecca C
Abstract excerpt
BACKGROUND: Previous genetic research in pediatric cardiomyopathy (CM) has focused on pathogenic variants for diagnostic purposes, with limited data evaluating genotype-outcome correlations. We explored whether greater genetic variant burden (pathogenic or variants of unknown significance, VUS) correlates with worse outcomes. METHODS: Children with dilated CM (DCM) and hypertrophic CM (HCM) who underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
